Stem Cell Transplantation For Cancer Treatment in NJ
RWJ Health Connect | Patient PortalGo
  • 1-888-MD-RWJUH
  • YouTube

Stem Cell Transplantation in New Jersey

The Blood and Marrow Transplant Program at Robert Wood Johnson University Hospital, in partnership with Rutgers Cancer Institute of New Jersey, has been performing transplants since 1995. The Blood and Marrow Transplant Program is the only program in the state of NJ that is part of an NCI-designated Comprehensive Cancer Center. The Blood and Marrow Transplant team performs stem cell transplants for patients with a variety of illnesses, including acute and chronic leukemias, myelodysplasia, various types of lymphoma, Hodgkin's disease, multiple myeloma, amyloidosis and related diseases.

At the Blood and Marrow Transplant Program, patients have access to clinical trials, state-of-the art technology, disease specific specialists—including the area’s best hematologic pathologists—and a full line of support services: social workers, dieticians, support groups, on-site pharmacy, and financial counselors.

There are several research initiatives within the Blood and Marrow Transplant program. In addition to participating in national and international clinical research studies with other transplant centers, there are unique research programs focusing on novel ways to: prevent graft-versus-host disease; improve umbilical cord blood transplants; and develop novel cellular therapies with less toxicity than standard transplants. The program is FACT accredited, has been rated as an "Excellent Program by the American College of Surgeons," and is certified by the National Marrow Donor Program.

About Stem Cell Transplants

Both autologous and allogeneic transplants are performed. Autologous transplants are when cells are harvested from the patient's bone marrow before chemotherapy and are replaced after cancer treatment. And allogeneic transplants are when stem cells come from a donor whose tissue most closely matches the patient, like a child, sibling or parent. Additional sources of transplant include matched unrelated donors and umbilical cord blood.

Stem Cell Transplant for Cancer Treatment

A stem cell transplant is a treatment that replaces defective or damaged cells in patients whose normal blood cells have been affected by cancer. Stem cell transplants are most often used for cancers affecting the blood or immune system, including leukemia, multiple myeloma, or some types of lymphoma. Transplants can also be used to help patients recover from or better tolerate cancer treatment, and to treat hereditary blood disorders such as sickle cell anemia.

To learn more about our cancer specialists, visit our physician finder.